AGRX - Agile Therapeutics Inc.'s (AGRX) CEO Al Altomari On Q4 2021 Results - Earnings Call Transcript
Agile Therapeutics, Inc. (AGRX) Q4 2021 Earnings Conference Call March 30, 2022 4:30 P.M. ET Company Participants Matt Riley - Head of Investors Relations Dennis Reilly - Chief Financial Officer Al Altomari - Chairman and Chief Executive Officer Conference Call Participants Leland Gershell - Oppenheimer Oren Livnat - H.C. Wainwright Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:06 Good afternoon, and welcome to the Agile Therapeutics’ Fourth Quarter and Full-Year 2021 Financial Results Conference Call. After today’s presentation there will be a question-and-answer session. [Operator Instructions] Please note today’s event is being recorded. 00:26 I would now like to turn the conference over to Matt Riley, Head
For further details see:
Agile Therapeutics, Inc.'s (AGRX) CEO Al Altomari On Q4 2021 Results - Earnings Call Transcript